Wealth Enhancement Advisory Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$669K Buy
6,661
+415
+7% +$37.4K ﹤0.01% 2420
2026
Q1
$544K Buy
6,246
+1,550
+33% +$136K ﹤0.01% 2253
2025
Q4
$397K Buy
4,696
+489
+12% +$39K ﹤0.01% 2663
2025
Q3
$316K Buy
4,207
+240
+6% +$16.6K ﹤0.01% 2745
2025
Q2
$264K Buy
+3,967
New +$258K ﹤0.01% 2743
2025
Q1
Sell
-4,298
Closed -$282K 3053
2024
Q4
$282K Buy
4,298
+1,065
+33% +$73.3K ﹤0.01% 2427
2024
Q3
$228K Sell
3,233
-12
-0.4% -$836 ﹤0.01% 2366
2024
Q2
$215K Buy
+3,245
New +$213K ﹤0.01% 2239

Other funds holding IHE